Please login to the form below

Not currently logged in
Email:
Password:

Meda

This page shows the latest Meda news and features for those working in and with pharma, biotech and healthcare.

Mylan agrees to buy Sweden's Meda for $7.2bn

Mylan agrees to buy Sweden's Meda for $7.2bn

After the deal goes through, the Mylan/Meda OTC business will have sales of around $1bn per year, a sizeable tally in a market that despite consolidation remains highly fragmented. ... Adding Meda enhances Mylan's presence in attractive markets such as

Latest news

  • Meda collaborates on asthma comic book Meda collaborates on asthma comic book

    Launches new Explain Asthma volume at ACAAI annual meeting. Meda and Medikiz have launched a new volume in a series of educational healthcare comic books for children. ... Asked why Meda chose to become involved in this project, Loesch said: “ Asthma

  • Cancer drugs lead SMC recommendations Cancer drugs lead SMC recommendations

    People with acne also have access to another treatment after the positive recommendation for Meda Pharmaceuticals' Treclin (clindamycin / tretinoin), while the SMC also gave the green light to the orphan drug

  • Meda agrees $3.1bn takeover of Italy's Rottapharm Meda agrees $3.1bn takeover of Italy's Rottapharm

    Meda said this morning the deal would expand its portfolio of specialty prescription drugs and consumer healthcare products, while also helping it to expand in emerging markets.  . ... which complement Meda's own operations in countries such as China

  • Sanofi won't take part in mega-deal trend Sanofi won't take part in mega-deal trend

    Meanwhile, rising Canadian company Valeant is also said to be interested in a $45bn merger with Allergan and generics firm Mylan is attempting to buy Swedish company Meda for $9bn.

  • Mylan raises offer for Meda to $9bn Mylan raises offer for Meda to $9bn

    The board's decision is based on a strong belief in the continued potential of Meda as a stand-alone company," said Meda in a statement issued this morning. ... Mylan's offer could be undermined by the reticence of one of its own shareholders, however,

More from news
Approximately 5 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2016 Deal Watch February 2016

    The deal value is approximately $9.9bn when including Meda's net debt, which represents a multiple of around 12.9 x 2015 adjusted EBITDA. ... Licensor Acquired/Licensee Acquirer. Product/Technology. Deal Type. Headline ($m). Meda/Mylan. portfolio of

  • Deal Watch table for July 2014 Deal Watch table for July 2014

    5, 300. Rottapharm/ Meda. Company acquisition   . Portfolio of Rx and consumer products.

  • Pharma deals during May 2014 Pharma deals during May 2014

    in Europe, Meda (rejected bid from Mylan), AMco and previously Nycomed (now owned by Takeda). The companies funded by debt provided by private equity are usually sold so Allergan's questions

  • Deal Watch table for August 2013 Deal Watch table for August 2013

    180. GardenHills /. Veropharm. Acquisition. Generic drug manufacture. 151. Acton Pharmaceuticals / Meda.

  • Pharma deals during May 2013 Pharma deals during May 2013

    month there were rumours circulating that the Indian generic company Sun Pharma is seeking to buy Meda for around $5bn. ... The same applies at Actavis and Mylan where R&D spending is 6 per cent of sales, which is typical of generic companies. Meda's

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Henrik Stenqvist joins Recipharm Henrik Stenqvist joins Recipharm

    Was previously CFO for Meda Group. Recipharm appoints Henrik Stenqvist as its new executive VP and chief financial officer, bringing 24 years of finance and management experience. ... Prior to joining Recipharm, Stenqvist served as CFO for Meda Group and

  • Virgo makes consumer health changes Virgo makes consumer health changes

    include Durex, Nurofen and Meda Pharma.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics